Instil Bio appoints Tim Moore as COO, CTO Vijay Chiruvolu resigns

Instil Bio, Inc.

Tim Moore appointed COO effective Sept 6, 2022; previously President/COO at PACT Pharma and EVP at Kite.
Moore receives $565K base salary, $100K signing bonus, 50% target bonus, and 750,000 stock option grant.
Separately, CTO Vijay Chiruvolu resigned on Sept 2, 2022; terms not disclosed.
Moore brings cell therapy manufacturing experience, including launch of Yescarta at Kite.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Timothy L. Moore

Chief Operating Officer

TIL · Instil Bio, Inc.

Effective: 2022-09-06
Filed: September 6, 2022, 7:59 PM ET

On September 6, 2022 (the “Effective Date”), the board of directors (the “Board”) of Instil Bio, Inc. (the “Company”) appointed Timothy L. Moore as Chief Operating Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy L. Moore was appointed as Chief Operating Officer at Instil Bio, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On September 6, 2022 (the “Effective Date”), the board of directors (the “Board”) of Instil Bio, Inc. (the “Company”) appointed Timothy L. Moore as Chief Operating Officer of the Company.

View on SEC.gov

Instil Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001789769-22-000077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.